DENTRESSANGLE Capital to acquire EDL from Abenex (exclusive negotiations)

September 23, 2024

DENTRESSANGLE Capital has entered exclusive negotiations to acquire EDL, a French European leader in medical imaging and diagnostic software, from Abenex. EDL, headquartered in Berre-l'Etang, France, has about 150 employees and ~€30m revenue and will continue its European expansion and AI-driven product development with support from DENTRESSANGLE and reinvestment from management.

Buyers
DENTRESSANGLE Capital
Targets
EDL
Sellers
Abenex
Location
Bouches-du-Rhône, France
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.